Mirum Pharmaceuticals, Inc. - stock earnings
MIRM Upcoming estimated earnings
| Date | Actual / Estimated EPS | Low Revenue | Actual / Estimated Revenue | High Revenue |
|---|---|---|---|---|
| May 2, 2024 AfterMarket | -0.66 / -0.49 | - | - / 71.6 million | - |
MIRM Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -33.1 million USD | 69.6 million USD |
| 2023Q3 | -23.6 million USD | 47.7 million USD |
| 2023Q2 | -74.0 million USD | 37.5 million USD |
| 2023Q1 | -30.1 million USD | 31.6 million USD |
| 2022Q4 | -36.4 million USD | 27.9 million USD |
| 2022Q3 | -35.7 million USD | 18.8 million USD |
| 2022Q2 | -26.9 million USD | 17.5 million USD |
| 2022Q1 | -36.6 million USD | 12.9 million USD |
| 2021Q4 | 57.5 million USD | 3.1 million USD |
| 2021Q3 | -47.1 million USD | 5.0 million USD |
| 2021Q2 | -43.9 million USD | 11.0 million USD |
| 2021Q1 | -50.5 million USD | ? USD |
| 2020Q4 | -37.2 million USD | ? USD |
| 2020Q3 | -21.5 million USD | ? USD |
| 2020Q2 | -23.3 million USD | ? USD |
| 2020Q1 | -21.3 million USD | ? USD |
| 2019Q4 | -18.0 million USD | ? USD |
| 2019Q3 | -15.1 million USD | ? USD |
| 2019Q2 | -13.6 million USD | ? USD |
| 2019Q1 | -6.0 million USD | ? USD |
| 2018Q3 | -67000 USD | ? USD |
MIRM Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -163.4 million USD | 186.4 million USD |
| 2022 | -135.7 million USD | 77.1 million USD |
| 2021 | -84.0 million USD | 19.1 million USD |
| 2020 | -103.3 million USD | 11.0 million USD |
| 2019 | -52.6 million USD | ? USD |
| 2018 | -17.3 million USD | ? USD |
MIRM
Price: $25.84
52 week price:
Earnings Per Share: -4.00 USD
P/E Ratio: -6.72
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Volume: 266732
Market Capitalization: 1.2 billion